Implementation and Effects of Nishauri on HIV Treatment Outcomes Among Men

NANot yet recruitingINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

April 20, 2026

Study Completion Date

July 17, 2026

Conditions
HIV Antiretroviral Therapy (ART) Adherence
Interventions
OTHER

Nishauri mHealth Intervention

The Nishauri mHealth intervention, developed by Palladium with Kenya's Ministry of Health and funded by PEPFAR/CDC, is a client-centered digital platform designed to enhance HIV care in Kenya. It supports appointment scheduling, ART referrals, and patient engagement through features such as automated medication and appointment reminders, tailored health education, two-way communication, and behavior-change strategies. Interoperable with national health systems like KenyaEMR and Ushauri, it enables real-time data exchange and continuity of care. Despite national scale-up, uptake remains low and varies across facilities, providers, and patients, particularly among men, who face unique sociocultural barriers. Addressing gender norms and contextual factors is key to improving implementation and achieving sustained engagement and better outcomes.

All Listed Sponsors
collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

Maseno University

OTHER

NCT07116538 - Implementation and Effects of Nishauri on HIV Treatment Outcomes Among Men | Biotech Hunter | Biotech Hunter